What was once niche has become a thriving mainstream industry. According to a Gallup poll, 64% of Americans are familiar with CBD and/or CBD products.
KND Labs produces domestic hemp-derived cannabinoids such as cannabidiol (CBD), cannabigerol (CBG) and cannabinol (CBN). The companies said the partnership allows them to offer clean-label extraction, transparent third-party testing and grower-direct supply assurance to a number of industries, including nutraceuticals.
“KND Labs brings a high level of testing, safety, compliance and third-party certifications that our customers have come to expect from HFI,” said Jay Johnson, chief operating officer for HFI. “The team at KND [is] leading industry standards within the hemp sector. We were very intentional in identifying an experienced strategic supply partner that shares our commitment to the industry and [is] helping us to realize our mission of nourishing lives with healthy ingredients.”
According to HFI, KND uses industry-leading methods to carefully extract and formulate premium-quality finished bulk ingredients, including those that are THC-free, in its two state-of-the-art facilities. KND manages the manufacturing process of its hemp-derived ingredients by extracting specific cannabinoid profiles to produce CBD, CBG and the isolation of other hemp-derived cannabinoids in a variety of forms, including powdered isolate, distillate oils and liquid and powder water-soluble products. KND offers custom formulations with batch consistency for various cannabinoid profiles to meet customers’ requirements.